No dose limiting toxicities were reported in the first cohort of ultra-high concentration of nitric ...
Blog
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Data describe a potent systemic immune response resulting in a significant reduction in challenge tu...
Data showing UNO in combination with anti-PD-1 treatment leads to significantly higher tumor regress...
Data suggests ultra-high concentration gaseous NO (gNO) induced both innate and adaptive immune cell...
Abstracts for the American Association for Cancer Research (AACR) Annual Meeting were released publi...
Mr. David Dvorak, previously the President and CEO of Zimmer Biomet, brings a 25+ year proven track ...
Beyond Air® retains 80% equity ownership of Beyond Cancer™, reaching the maximum allowable allotment...
$23.9 million committed in concurrent equity private placement to form Beyond Cancer that will lever...
Drive people to your products and services
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.